As India observes World Hepatitis Day tomorrow, the Institute of Liver and Biliary Sciences (ILBS) based in New Delhi today painted a grim picture on prevalence of various forms of Hepatitis infection in the country and efforts to check it, saying the country's collective efforts in this field are "limited and painfully lagging behind".
Every year, nearly 600,000 patients die from HBV infection in the region but the government does not yet have national policies relating to screening and referral for Hepatitis B or Hepatitis C, it said.
Hepatitis B is a serious global health problem, responsible for 1.4 million deaths every year compared to 1.5 million deaths from HIV/AIDS and 1.2 million from each of malaria and TB, the ILBS said.
"India has over 40 million hepatitis B (HBV) infected patients (second only to China) and constitutes about 15 per cent of the entire pool of hepatitis B in the world.
"Tribal areas in India have high prevalence of hepatitis B. Every year, nearly 600,000 patients die from HBV infection in the Indian continent," the ILBL statement said.
"There has been lot of talk about Hepatitis and its adverse effect and its now time for action. Our aim is to rid India of all forms of Hepatitis infections by 2080," ILBS Director Shiv Sarin said.
On the occasion of World Hepatitis Day 2014, ILBS in partnership with the WHO India is organising the first ever consultation meeting on 'Viral Hepatitis In India Gaps, Challenges and Priorities' on July 28.
This year's theme, 'Think Again' acknowledges that "we do not know nearly enough about viral hepatitis as a health threat in much of the world", it said.
The national experts together with stakeholders from the government, academia, clinicians, public health experts, civil society, research institutions and partner agencies are going to be a part of this meeting, ILBS said.
"Most people with chronic hepatitis B or C are unaware of their infection and are at serious risk of developing cirrhosis or liver cancer," the statement said.
The study said that Hepatitis A virus (HAV) is responsible for 10-30 per cent of acute hepatitis and 5-15 per cent of acute liver failure cases in India and there is a vaccine available for HAV.